MA49521A - Nanoparticule, agent de contraste pour imagerie par résonance magnétique la contenant, et composé ligand - Google Patents
Nanoparticule, agent de contraste pour imagerie par résonance magnétique la contenant, et composé ligandInfo
- Publication number
- MA49521A MA49521A MA049521A MA49521A MA49521A MA 49521 A MA49521 A MA 49521A MA 049521 A MA049521 A MA 049521A MA 49521 A MA49521 A MA 49521A MA 49521 A MA49521 A MA 49521A
- Authority
- MA
- Morocco
- Prior art keywords
- nanoparticle
- contrast
- agent
- magnetic resonance
- resonance imaging
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Composite Materials (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017126755 | 2017-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA49521A true MA49521A (fr) | 2020-05-06 |
Family
ID=64742350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA049521A MA49521A (fr) | 2017-06-28 | 2018-06-27 | Nanoparticule, agent de contraste pour imagerie par résonance magnétique la contenant, et composé ligand |
Country Status (19)
Country | Link |
---|---|
US (1) | US11389550B2 (fr) |
EP (1) | EP3646888A4 (fr) |
JP (1) | JP7107532B2 (fr) |
KR (1) | KR20200018579A (fr) |
CN (1) | CN110799219B (fr) |
AU (1) | AU2018292927B2 (fr) |
BR (1) | BR112019027478A2 (fr) |
CA (1) | CA3068215A1 (fr) |
CO (1) | CO2020000940A2 (fr) |
IL (1) | IL271622A (fr) |
JO (1) | JOP20190290A1 (fr) |
MA (1) | MA49521A (fr) |
MY (1) | MY201491A (fr) |
PH (1) | PH12019502882A1 (fr) |
RU (1) | RU2767430C2 (fr) |
SG (1) | SG11201912664WA (fr) |
UA (1) | UA125049C2 (fr) |
WO (1) | WO2019004297A1 (fr) |
ZA (1) | ZA202000265B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2021007731A (es) * | 2018-12-27 | 2021-08-05 | Astellas Pharma Inc | Nanoparticula, agente de contraste para formacion de imagenes por resonancia magnetica que comprende la misma y un compuesto de ligando zwitterionico. |
MX2021007832A (es) * | 2018-12-27 | 2021-08-11 | Astellas Pharma Inc | Metodo para producir nanoparticulas que tienen particulas metalicas que contienen oxido de hierro a las cuales se unen por coordinacion uno o mas ligandos hidrofilos. |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123542A (en) | 1960-10-13 | 1964-03-03 | Electrolytic marking medium | |
US20100166664A1 (en) | 2008-12-29 | 2010-07-01 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
US8574549B2 (en) | 2008-12-29 | 2013-11-05 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
US8728440B2 (en) | 2012-08-23 | 2014-05-20 | General Electric Company | Nanoparticulate compositions for diagnostic imaging |
US9399075B2 (en) | 2008-12-29 | 2016-07-26 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
CN102333547A (zh) | 2008-12-29 | 2012-01-25 | 通用电气公司 | 用于诊断成像的纳米颗粒造影剂 |
US8728529B2 (en) | 2008-12-29 | 2014-05-20 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
US9205155B2 (en) | 2009-10-30 | 2015-12-08 | General Electric Company | Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents |
KR20130045647A (ko) * | 2011-10-26 | 2013-05-06 | 한국기초과학지원연구원 | 양쪽성 이온으로 코팅된 자기공명영상 조영제 |
WO2013090601A2 (fr) | 2011-12-16 | 2013-06-20 | Massachusetts Institute Of Technology | Nanoparticules compactes pour des applications biologiques |
US8821838B2 (en) | 2012-08-23 | 2014-09-02 | General Electric Company | Nanoparticulate compositions for diagnostic imaging |
CN104740654B (zh) | 2013-12-30 | 2017-12-29 | 中国科学院化学研究所 | 磁性纳米颗粒磁共振造影剂和增强磁性纳米颗粒弛豫率的方法 |
JP6590809B2 (ja) | 2014-01-07 | 2019-10-16 | コロロッビア イタリア ソシエタ ペル アチオニ | カテコールで官能化された磁性ナノ粒子、その生成および使用 |
JP6471227B2 (ja) | 2014-09-15 | 2019-02-13 | マサチューセッツ インスティテュート オブ テクノロジー | 磁気共鳴画像法用途のためのナノ粒子 |
JP6577250B2 (ja) | 2015-06-02 | 2019-09-18 | 国立大学法人 東京大学 | 複合半透膜 |
CN106390146A (zh) | 2015-08-03 | 2017-02-15 | 天津大学 | 聚磺酸甜菜碱两性电解质修饰的磁性纳米粒子及其制备方法和应用 |
-
2018
- 2018-06-27 BR BR112019027478-2A patent/BR112019027478A2/pt unknown
- 2018-06-27 WO PCT/JP2018/024416 patent/WO2019004297A1/fr unknown
- 2018-06-27 RU RU2019143780A patent/RU2767430C2/ru active
- 2018-06-27 MY MYPI2019007668A patent/MY201491A/en unknown
- 2018-06-27 KR KR1020207000498A patent/KR20200018579A/ko not_active Application Discontinuation
- 2018-06-27 JP JP2019526990A patent/JP7107532B2/ja active Active
- 2018-06-27 EP EP18823223.5A patent/EP3646888A4/fr not_active Withdrawn
- 2018-06-27 MA MA049521A patent/MA49521A/fr unknown
- 2018-06-27 UA UAA202000282A patent/UA125049C2/uk unknown
- 2018-06-27 CA CA3068215A patent/CA3068215A1/fr active Pending
- 2018-06-27 SG SG11201912664WA patent/SG11201912664WA/en unknown
- 2018-06-27 AU AU2018292927A patent/AU2018292927B2/en active Active
- 2018-06-27 US US16/624,946 patent/US11389550B2/en active Active
- 2018-06-27 CN CN201880041378.2A patent/CN110799219B/zh active Active
- 2018-12-28 JO JOP/2019/0290A patent/JOP20190290A1/ar unknown
-
2019
- 2019-12-19 IL IL271622A patent/IL271622A/en unknown
- 2019-12-19 PH PH12019502882A patent/PH12019502882A1/en unknown
-
2020
- 2020-01-15 ZA ZA2020/00265A patent/ZA202000265B/en unknown
- 2020-01-27 CO CONC2020/0000940A patent/CO2020000940A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN110799219B (zh) | 2023-01-06 |
CO2020000940A2 (es) | 2020-02-18 |
AU2018292927A1 (en) | 2020-02-06 |
UA125049C2 (uk) | 2021-12-29 |
BR112019027478A2 (pt) | 2020-07-07 |
EP3646888A1 (fr) | 2020-05-06 |
CA3068215A1 (fr) | 2019-01-03 |
WO2019004297A1 (fr) | 2019-01-03 |
JOP20190290A1 (ar) | 2019-12-19 |
MY201491A (en) | 2024-02-27 |
US20200330617A1 (en) | 2020-10-22 |
RU2767430C2 (ru) | 2022-03-17 |
RU2019143780A3 (fr) | 2021-08-27 |
KR20200018579A (ko) | 2020-02-19 |
JPWO2019004297A1 (ja) | 2020-04-30 |
ZA202000265B (en) | 2021-07-28 |
JP7107532B2 (ja) | 2022-07-27 |
PH12019502882A1 (en) | 2020-10-26 |
SG11201912664WA (en) | 2020-01-30 |
RU2019143780A (ru) | 2021-06-25 |
IL271622A (en) | 2020-02-27 |
EP3646888A4 (fr) | 2021-04-14 |
US11389550B2 (en) | 2022-07-19 |
CN110799219A (zh) | 2020-02-14 |
AU2018292927B2 (en) | 2021-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL284686A (en) | Treatment of beta-thalassemia using ACTRII ligand traps | |
IL264598A (en) | Antibody-protein nanoparticle complexes adapted for cancer therapy | |
DK3303307T3 (da) | Nye gadoliniumchelatforbindelser til anvendelse til magnetisk resonans-billeddannelse | |
IL253394A0 (en) | Heterocyclic compounds for cancer imaging and treatment and methods of using them | |
MA41052A (fr) | Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii | |
MA52252A (fr) | Formulation de poudre nasale pour le traitement de l'hypoglycémie | |
FR3006562B3 (fr) | Article pour chaussure qui empeche le pied d'une personne la portant de glisser hors de la chaussure | |
DK3241551T3 (da) | Farmaceutisk sammensætning til behandling af kræft, indeholdende lactatmetalsalt | |
MA49521A (fr) | Nanoparticule, agent de contraste pour imagerie par résonance magnétique la contenant, et composé ligand | |
IL272571A (en) | NR4A1 ligands, pharmaceutical compositions, and related methods of use | |
EP3491007A4 (fr) | Ligands radiomarqués pour imagerie pet/spect ciblée et leurs procédés d'utilisation | |
EP3363466A4 (fr) | Procédé de préparation d'agent de contraste pour imagerie par résonance magnétique | |
IT201700105483A1 (it) | Metodo per la diagnosi e la prognosi di patologie neurodegenerative e neuroinfiammatorie | |
ZA202104733B (en) | Nanoparticle, contrast agent for magnetic resonance imaging comprising same and zwitterionic ligand compound | |
ITUB20161119A1 (it) | Sistema per la gestione semplificata e sicura degli accessi e delle emergenze | |
EP2910547A4 (fr) | Composé, tautomère et isomère géométrique de celui-ci, sel dudit composé, tautomère ou isomère géométrique, procédé de fabrication dudit composé, tautomère, isomère ou sel, ainsi qu'agent antimicrobien et médicament anti-infectieux | |
EP3359870C0 (fr) | Chariot modulaire pour l'enregistrement de donnees magnetique de terrain notamment pour le controle non invasif de pipelines ou similaires | |
FR3005855B1 (fr) | Obturateur d'un connecteur pour poche de perfusion | |
ITUA20163044A1 (it) | Dispositivo magnetico per la cattura di impurita' ferrose nei carri trincia miscelatori di foraggi unifeed | |
IT201700035316A1 (it) | Metodo e sistema di cooperazione tra access gateway per la condivisione di banda | |
FR3038641B3 (fr) | Serrure pour porte d' interieur | |
FR3035877B1 (fr) | Ensemble formant anneau de mors, notamment pour cheval | |
MA42309A (fr) | Nouveau composé de tiacumicine pour régime posologique | |
ITUB20152571A1 (it) | Dispositivo multifunzione per la movimentazione e il trattamento di forme di formaggio. | |
GB201709715D0 (en) | Contrast agents for magnetic resonance imaging |